Intercept Pharmaceuticals (ICPT) News Today

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Analyst Forecasts Earnings Headlines Ownership Social Media Sustainability

Source

Source	Headline
	89bio gains 47% on topline data for NASH candidate msn.com - March 21 at 6:15 PM
	Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC globenewswire.com - February 29 at 8:30 AM
	Intercept Announces New Phase 2 Data Showing Significant Impact of OCA-Bezafibrate Combination on Normalization of Multiple Key Biomarkers of PBC-Induced Liver Damage at AASLD The Liver Meeting® 2023 finance.yahoo.com - November 13 at 10:04 AM
	Intercept Announces New Findings from Long-term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD The Liver Meeting® 2023 finance.yahoo.com - November 10 at 8:38 AM
	marketbeat.com - November 8 at 6:11 AM
	Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc. finance.yahoo.com - November 8 at 3:49 AM
	Intercept Pharmaceuticals (ICPT) Price Target Increased by 6.63% to 19.38 msn.com - November 2 at 10:57 PM
	Will Intercept Pharmaceuticals (ICPT) Report Negative Q3 Earnings? What You Should Know finance.yahoo.com - October 31 at 1:27 PM
	Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now finance.yahoo.com - October 27 at 2:49 AM
	Intercept Pharmaceuticals (NASDAQ:ICPT) shareholders have endured a 83% loss from investing in the stock five years ago finance.yahoo.com - October 11 at 12:51 PM
	Intercept Pharmaceuticals (ICPT) Price Target Increased by 21.49% to 18.17 msn.com - October 5 at 10:40 PM
	Intercept Pharma unlikely to see rival offers, other roadblocks, analysts say msn.com - September 28 at 10:48 PM
	Canaccord Genuity Downgrades Intercept Pharmaceuticals (ICPT) msn.com - September 28 at 10:48 PM
	Royal Bank of Canada Increases Intercept Pharmaceuticals (NASDAQ:ICPT) Price Target to $19.00 marketbeat.com - September 27 at 9:40 AM
	Intercept Pharma Acquisition by Alfasigma: A Strategic Move and Fair Value Assessment markets.businessinsider.com - September 27 at 5:01 AM
	Intercept Pharmaceuticals stock soars on Alfasigma acquisition deal proactiveinvestors.com - September 27 at 5:01 AM
	Canaccord cuts Intercept to hold, calls Alfasigma deal "best possible outcome" msn.com - September 26 at 9:08 PM
	Shareholder Alert: Ademi LLP investigates whether Intercept Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Alfasigma benzinga.com - September 26 at 4:07 PM
	Intercept Pharmaceuticals: Alfasigma Pays Premium For M&A Deal That Suits All Parties seekingalpha.com - September 26 at 3:35 PM
	Why Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today? investorplace.com - September 26 at 3:10 PM
	Intercept Pharma Shares Surge Toward Alfasigma Acquisition Price marketwatch.com - September 26 at 11:07 AM
	Intercept Pharmaceuticals’ stock set to soar after Alfasigma buyout deal for an 82% premium msn.com - September 26 at 11:07 AM
	Italy's Alfasigma to buy drugmaker Intercept for nearly $800 mln reuters.com - September 26 at 11:07 AM
	Alfasigma To Acquire Intercept Pharma Fo $19 Per Share In Cash markets.businessinsider.com - September 26 at 11:07 AM
	Why Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today? markets.businessinsider.com - September 26 at 11:07 AM
	Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases finance.yahoo.com - September 26 at 11:07 AM
	UPDATE 2-Italy's Alfasigma to buy US liver disease drugmaker Intercept for nearly $800 mln finance.yahoo.com - September 26 at 11:07 AM
	marketbeat.com - September 26 at 7:59 AM
	FY2025 EPS Estimates for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Lifted by Zacks Research marketbeat.com - September 20 at 6:38 AM
	Intercept Pharma (ICPT) Receives a Hold from RBC Capital markets.businessinsider.com - September 9 at 12:09 AM
	Why CymaBay Therapeutics Stock Is Jumping Today finance.yahoo.com - September 8 at 2:08 PM
	Why Is Fate Therapeutics (FATE) Down 23.5% Since Last Earnings Report? finance.yahoo.com - September 7 at 3:39 PM
	Credit Suisse AG Has $1.71 Million Stock Holdings in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) marketbeat.com - September 6 at 4:24 AM
	ExodusPoint Capital Management LP Has $1.04 Million Stock Holdings in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) marketbeat.com - September 5 at 5:27 AM
	Why Is Intercept (ICPT) Up 0.6% Since Last Earnings Report? finance.yahoo.com - September 1 at 5:23 PM
	Leerink Partnrs Equities Analysts Lift Earnings Estimates for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) marketbeat.com - August 28 at 2:18 AM
	Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Shares Acquired by Pictet Asset Management SA marketbeat.com - August 23 at 6:10 AM
	Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Shares Bought by Mirae Asset Global Investments Co. Ltd. marketbeat.com - August 22 at 4:21 AM
	Q3 2023 Earnings Forecast for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Issued By Zacks Research marketbeat.com - August 21 at 1:52 AM
	Zacks Research Weighs in on Intercept Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:ICPT) marketbeat.com - August 18 at 8:18 AM
	Intercept Pharmaceuticals (NASDAQ:ICPT) Downgraded to Hold at StockNews.com marketbeat.com - August 11 at 1:10 AM
	B. Riley Weighs in on Intercept Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:ICPT) marketbeat.com - August 7 at 8:28 AM
	Canaccord Genuity Maintains Intercept Pharmaceuticals (ICPT) Buy Recommendation msn.com - August 4 at 2:38 AM
	Intercept: Narrowed Market, Concentrated Strategy (Rating Upgrade) seekingalpha.com - August 3 at 6:45 PM
	Intercept Pharmaceuticals, Inc.: Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates finanznachrichten.de - August 2 at 1:17 PM
	Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates finance.yahoo.com - August 2 at 1:17 PM
	Intercept (ICPT) Q2 Earnings Top Estimates, Revenues Up Y/Y finance.yahoo.com - August 2 at 1:16 PM
	Intercept Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation seekingalpha.com - August 2 at 9:36 AM
	Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Receives Average Recommendation of "Moderate Buy" from Brokerages marketbeat.com - August 2 at 2:44 AM
	Arizona State Retirement System Makes New Investment in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) marketbeat.com - August 1 at 6:15 AM

Get Intercept Pharmaceuticals News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

ICPT Media Mentions By Week

ICPT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ICPT
News Sentiment
▼
0.30

0.38
▲
Average
Medical
News Sentiment

ICPT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ICPT Articles
This Week
▼
0

2
▲
ICPT Articles
Average Week

Get Intercept Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ICPT) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Intercept Pharmaceuticals (ICPT) News Today

ICPT Media Mentions By Week

ICPT Media Sentiment

ICPT News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info